NCT03464500

AMAZ-02 Effect on Exercise ToLerance in Healthy, Overweight Middle Aged Subjects (ATLAS Trial)

A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy of AMAZ-02 on Muscle Function in Otherwise Healthy Middle-aged, Overweight and Inactive Individuals

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 90 (actual)
• Sponsor: Amazentis SA · Industry
• Sex: All
• Age: 40 Years – 65 Years
• Healthy volunteers: Accepted

Summary

This is a Phase 2 randomized, double-blind, placebo-controlled study enrolling 90 healthy, overweight, middle aged subjects (30 placebo, 30 low dose and 30 high dose AMAZ-02 intervention), 40-65 years of age, who are otherwise healthy. AMAZ-02, a food derived ingredient, will be given as a daily oral dose for 4 months.

Conditions

• Muscle Function, Mitochondrial Function
• Overweight
• Healthy Aging

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Mitopure 500mg	Mitopure containing softgels
DIETARY_SUPPLEMENT	Mitopure 1000mg	Mitopure containing softgels
DIETARY_SUPPLEMENT	Placebo	Placebo containing softgels

Timeline

• Start date: 2018-03-06
• Primary completion: 2019-09-30
• Completion: 2019-09-30
• First posted: 2018-03-14
• Last updated: 2022-08-17

Locations

1 site across 1 country: Canada